関連する実験動画
Updated: Jan 13, 2026

07:02
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
7.8K
IGF2BP2はm6A依存性STAT1 mRNA不安定化を介して甲状腺癌の脱分化を駆動する
Rui Chen1, Yi-Xun Li1, Wei-Lin Lu1
1Department of Breast Surgery, the First Affiliated Hospital with Nanjing Medical University, 300 Guangzhou Road, 210029, Nanjing, People's Republic of China.
International journal of biological sciences
|January 12, 2026
まとめ
IGF2BP2は、STAT1 mRNAを標的とすることにより甲状腺癌の脱分化を駆動し、攻撃的な未分化甲状腺癌(ATC)につながります。この発見は、進行した甲状腺癌の再分化療法のための新しい治療標的を提供します。
科学分野:
- 内分泌学
- 腫瘍学
- 分子生物学
背景:
- 甲状腺癌は一般的な内分泌悪性腫瘍です。
- 未分化甲状腺癌(ATC)は、脱分化型乳頭癌(PTC)から生じる攻撃的で致死的なサブタイプです。
- PTCからATCへの脱分化を駆動する分子メカニズムは、ほとんど知られていません。
主な方法:
- 遺伝子発現の擬似時間軌跡解析。
- 細胞増殖、分化、がん幹細胞性を評価する機能的アッセイ。
- RNA-seq、RIP-seq、MeRIP-seqを含む統合マルチオミクス解析。
- メカニズム的発見を検証するためのレスキュー実験。
結論:
- IGF2BP2-m6A-STAT1複合体は、甲状腺癌の脱分化の主要な調節因子です。
- この複合体を標的とすることは、進行した甲状腺癌の再分化療法のための新しい治療戦略を表します。
関連する概念動画
TGF - β Signaling Pathway
10.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.4K
Master Transcription Regulators
7.7K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.7K
Abnormal Proliferation
5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K
Mitogens and the Cell Cycle
7.7K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.7K
PI3K/mTOR/AKT Signaling Pathway
5.3K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.3K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K

